AbCellera Biologics Inc. (ABCL) vs Tango Therapeutics, Inc. (TNGX)
A side-by-side comparison of AbCellera Biologics Inc. and Tango Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABCL
AbCellera Biologics Inc.
$13.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TNGX
Tango Therapeutics, Inc.
$21.90HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ABCL vs TNGX
growth of $100 · dividends reinvested · last 6yABCL -76.6% (-21.5%/yr)TNGX +105.9% (+12.8%/yr)TNGX compounded faster over this window
Log scale — wide-divergence pair
ABCL TNGX
ABCL vs TNGX: by the numbers
- •ABCL is the larger company ($4.02B vs $3.57B market cap).
- •Both run net losses; TNGX's is the smaller (-229.92% vs -248.83% net margin).
- •TNGX grew revenue faster over the past five years (19.14% vs -31.78% CAGR).
Metrics side by side
Valuation
| Metric | ABCL | TNGX |
|---|---|---|
| P/S ratio | 60.68 | 66.26 |
| P/B ratio | 4.48 | 3.48 |
Profitability
| Metric | ABCL | TNGX |
|---|---|---|
| Gross margin | 61.64% | 98.25% |
| Operating margin | -288.98% | -178.39% |
| Net margin | -248.83% | -229.92% |
| ROE | -18.38% | -12.08% |
| ROIC | -17.95% | -12.91% |
Growth (annualized)
| Metric | ABCL | TNGX |
|---|---|---|
| Revenue CAGR (5Y) | -31.78% | 19.14% |
| Total return CAGR (5Y) | -3.57% | 10.60% |
Frequently asked
- Which has grown faster, ABCL or TNGX?
- Over the past five years, TNGX grew revenue faster — ABCL at a -31.78% CAGR versus TNGX at 19.14%.
- How have ABCL and TNGX total returns compared?
- Over the past 5 years, ABCL delivered -3.57% and TNGX delivered 10.60% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbCellera Biologics ROETango Therapeutics ROEAbCellera Biologics operating marginTango Therapeutics operating marginAbCellera Biologics revenue growthTango Therapeutics revenue growthAbCellera Biologics free cash flowTango Therapeutics free cash flow
AbCellera Biologics & Tango Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.